These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 29764768)
21. Supervillin promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma in hypoxia via activation of the RhoA/ROCK-ERK/p38 pathway. Chen X; Zhang S; Wang Z; Wang F; Cao X; Wu Q; Zhao C; Ma H; Ye F; Wang H; Fang Z J Exp Clin Cancer Res; 2018 Jun; 37(1):128. PubMed ID: 29954442 [TBL] [Abstract][Full Text] [Related]
22. Diverse molecular functions of aspartate β‑hydroxylase in cancer (Review). Zheng W; Wang X; Hu J; Bai B; Zhu H Oncol Rep; 2020 Dec; 44(6):2364-2372. PubMed ID: 33125119 [TBL] [Abstract][Full Text] [Related]
23. The Rho GTPase Rnd1 inhibits epithelial-mesenchymal transition in hepatocellular carcinoma and is a favorable anti-metastasis target. Qin CD; Ma DN; Zhang SZ; Zhang N; Ren ZG; Zhu XD; Jia QA; Chai ZT; Wang CH; Sun HC; Tang ZY Cell Death Dis; 2018 May; 9(5):486. PubMed ID: 29706627 [TBL] [Abstract][Full Text] [Related]
24. NTS/NTR1 co-expression enhances epithelial-to-mesenchymal transition and promotes tumor metastasis by activating the Wnt/β-catenin signaling pathway in hepatocellular carcinoma. Ye Y; Long X; Zhang L; Chen J; Liu P; Li H; Wei F; Yu W; Ren X; Yu J Oncotarget; 2016 Oct; 7(43):70303-70322. PubMed ID: 27611941 [TBL] [Abstract][Full Text] [Related]
25. Basil polysaccharide inhibits hypoxia-induced hepatocellular carcinoma metastasis and progression through suppression of HIF-1α-mediated epithelial-mesenchymal transition. Feng B; Zhu Y; Sun C; Su Z; Tang L; Li C; Zheng G Int J Biol Macromol; 2019 Sep; 137():32-44. PubMed ID: 31252022 [TBL] [Abstract][Full Text] [Related]
27. MXR7 facilitates liver cancer metastasis via epithelial-mesenchymal transition. Lv G; Tan Y; Lv H; Fang T; Wang C; Li T; Yu Y; Hu C; Wen W; Wang H; Yang W Sci China Life Sci; 2017 Nov; 60(11):1203-1213. PubMed ID: 28812296 [TBL] [Abstract][Full Text] [Related]
28. HCC-derived exosomes elicit HCC progression and recurrence by epithelial-mesenchymal transition through MAPK/ERK signalling pathway. Chen L; Guo P; He Y; Chen Z; Chen L; Luo Y; Qi L; Liu Y; Wu Q; Cui Y; Fang F; Zhang X; Song T; Guo H Cell Death Dis; 2018 May; 9(5):513. PubMed ID: 29725020 [TBL] [Abstract][Full Text] [Related]
29. CAPZA1 modulates EMT by regulating actin cytoskeleton remodelling in hepatocellular carcinoma. Huang D; Cao L; Zheng S J Exp Clin Cancer Res; 2017 Jan; 36(1):13. PubMed ID: 28093067 [TBL] [Abstract][Full Text] [Related]
30. GP73 promotes epithelial-mesenchymal transition and invasion partly by activating TGF-β1/Smad2 signaling in hepatocellular carcinoma. Yang Y; Liu Q; Li Z; Zhang R; Jia C; Yang Z; Zhao H; Ya S; Mao R; Ailijiang T; Bao Y; Zhang H Carcinogenesis; 2018 Jul; 39(7):900-910. PubMed ID: 29365054 [TBL] [Abstract][Full Text] [Related]
31. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma. Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092 [TBL] [Abstract][Full Text] [Related]
32. Delphinidin inhibits epidermal growth factor-induced epithelial-to-mesenchymal transition in hepatocellular carcinoma cells. Lim WC; Kim H; Ko H J Cell Biochem; 2019 Jun; 120(6):9887-9899. PubMed ID: 30537288 [TBL] [Abstract][Full Text] [Related]
33. MAP4K4 promotes epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma. Feng XJ; Pan Q; Wang SM; Pan YC; Wang Q; Zhang HH; Zhu MH; Zhang SH Tumour Biol; 2016 Aug; 37(8):11457-67. PubMed ID: 27010469 [TBL] [Abstract][Full Text] [Related]
34. Anti-Tumor Effects of Second Generation β-Hydroxylase Inhibitors on Cholangiocarcinoma Development and Progression. Huang CK; Iwagami Y; Aihara A; Chung W; de la Monte S; Thomas JM; Olsen M; Carlson R; Yu T; Dong X; Wands J PLoS One; 2016; 11(3):e0150336. PubMed ID: 26954680 [TBL] [Abstract][Full Text] [Related]
35. Dihydropyrimidine dehydrogenase predicts survival and response to interferon-α in hepatocellular carcinoma. Zhu WP; Liu ZY; Zhao YM; He XG; Pan Q; Zhang N; Zhou JM; Wang LR; Wang M; Zhan DH; Ma DN; Wang L Cell Death Dis; 2018 Jan; 9(2):69. PubMed ID: 29358721 [TBL] [Abstract][Full Text] [Related]
36. Aspartate β-Hydroxylase Is Upregulated in Head and Neck Squamous Cell Carcinoma and Regulates Invasiveness in Cancer Cell Models. Mukherjee P; Zhou X; Galli S; Davidson B; Zhang L; Ahn J; Aljuhani R; Benicky J; Ailles L; Pomin VH; Olsen M; Goldman R Int J Mol Sci; 2024 May; 25(9):. PubMed ID: 38732216 [TBL] [Abstract][Full Text] [Related]
37. Monoacylglycerol lipase promotes progression of hepatocellular carcinoma via NF-κB-mediated epithelial-mesenchymal transition. Zhu W; Zhao Y; Zhou J; Wang X; Pan Q; Zhang N; Wang L; Wang M; Zhan D; Liu Z; He X; Ma D; Liu S; Wang L J Hematol Oncol; 2016 Nov; 9(1):127. PubMed ID: 27884159 [TBL] [Abstract][Full Text] [Related]
38. MicroRNA-1296 inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting SRPK1-mediated PI3K/AKT pathway. Xu Q; Liu X; Liu Z; Zhou Z; Wang Y; Tu J; Li L; Bao H; Yang L; Tu K Mol Cancer; 2017 Jun; 16(1):103. PubMed ID: 28606154 [TBL] [Abstract][Full Text] [Related]
40. [The role of hexokinase 2 in the metastasis of hepatocellular carcinoma cells]. Geng XL; Long WH; Hai J; Zhang Y; Zheng W; Zhang ZY; Du LX Zhonghua Zhong Liu Za Zhi; 2016 Oct; 38(10):739-742. PubMed ID: 27784456 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]